The FDA approved oral benzgalantamine (Zunveyl) to treat symptoms of mild-to-moderate Alzheimer's disease, Alpha Cognition announced on Monday. A prodrug of galantamine and an acetylcholinesterase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback